Surgery Partners, Inc. (SGRY) stock
Close on Nov 11, 2026Market cap $3.49BP/E –Yield –
Surgery Partners, Inc. grew revenue 2.2% to $3.36B over the twelve months to Sep 30, 2026. Operating income fell 10.5% to $363.70M, moving the operating margin from 12.4% to 10.8%. Free cash flow was $202.80M, up 4.5% from a year earlier. At the latest close the market valued the company at $3.49B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $3.49B
- P/E ratio
- –
- Price to sales
- 1.04
- Price to book
- 2.10
- Dividend yield
- –
- Free cash flow yield
- 5.81%
Fundamentals
- Revenue
- $3.36B
- Net income
- -$87.00M
- EPS, diluted
- -$0.68
- Free cash flow
- $202.80M
- Book value per share
- $12.92
- Diluted shares
- 129M
Trading
- Next earnings
- Mar 1, 2027 (estimated, after the close)
- Previous close
- $26.73
- Open
- $26.39
- Day's range
- $26.39 – $26.70
- Volume
- 2,607,730
- Average volume (20 days)
- 7,530,351
- Index membership
- Russell 2000, Russell 3000
- Beta (5 years)
- 1.57
- 52-week range
- $11.41 – $27.23
- RSI (14 days)
- 90.2
- Volatility (1 year)
- 66.8%
- Relative volume
- 0.80×
- WACC
- 9.3%
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2015, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | SGRY | S&P 500 | Difference | SGRY per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +91.9% | -2.4% | +94.3 pts | ||
| 3 months | +77.7% | -1.2% | +78.9 pts | ||
| Year to date | +72.6% | +12.3% | +60.3 pts | ||
| 1 year | +69.3% | +12.4% | +56.9 pts | ||
| 3 years | +1.8% | +78.8% | −77.0 pts | +0.6% | +21.4% |
| 5 years | -47.1% | +75.2% | −122.3 pts | -12.0% | +11.9% |
| 10 years | +77.1% | +311.1% | −234.0 pts | +5.9% | +15.2% |
Fourteen years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Surgery Partners filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Results
- Results
- Update
About Surgery Partners
Services-General Medical & Surgical Hospitals, NEC
Surgery Partners, Inc. operates an integrated network of surgical facilities and related ancillary healthcare services across the United States. Through its sole reportable segment, Surgical Facilities, the company manages ambulatory surgery centers, short-stay surgical hospitals, multi-specialty physician practices, urgent care centers, and anesthesia services. Its clinical facilities focus on non-emergency, elective, and planned outpatient procedures across specialties such as orthopedics, pain management, ophthalmology, gastroenterology, and general surgery. The organization serves individual patients while partnering closely with independent physicians and regional health systems. Services are primarily reimbursed by commercial health plans and government payers such as Medicare and Medicaid, alongside self-pay patients.
Company profile, executives and historySurgery Partners stock: common questions
What is Surgery Partners's stock price?
SGRY closed at $26.66 on Nov 11, 2026, down 0.26% on the day. Over the past 52 weeks it traded between $11.41 and $27.23.
What is Surgery Partners's market cap?
Surgery Partners was worth $3.49B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is SGRY's P/E ratio?
Surgery Partners lost money over the twelve months to Sep 30, 2026 (diluted EPS -$0.68), so it has no meaningful P/E ratio.
How much revenue does Surgery Partners make?
Surgery Partners reported revenue of $3.36B for the twelve months to Sep 30, 2026, up 2.2% from a year earlier.
Does Surgery Partners pay a dividend?
No. Surgery Partners has not paid a cash dividend over the last twelve months.
When does Surgery Partners report earnings next?
Surgery Partners is expected to report Q4 FY2026 results on Mar 1, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has SGRY stock performed over the past year?
Including dividends, SGRY returned +69.3% over the past year, against +12.4% for the S&P 500.
How many SGRY shares are sold short?
9M shares were sold short at the latest FINRA report, 48.58% of the float, or 1.1 days of average trading volume.
Who are Surgery Partners's competitors?
Companies most similar to Surgery Partners by business, industry and size include ARDT, CYH, UHS, THC, MD.
See a number that looks wrong?